Clinical aspects of a phase I study of PD-0325901, a selective oral MEK inhibitor, in patients with advanced cancer Meeting Abstract
| Authors: | LoRusso, P. A.; Krishnamurthi, S. S.; Rinehart, J. J.; Nabell, L. M.; Croghan, G. A.; Chapman, P. B.; Selaru, P.; Kim, S.; Ricart, A. D.; Wilner, K. D. |
| Abstract Title: | Clinical aspects of a phase I study of PD-0325901, a selective oral MEK inhibitor, in patients with advanced cancer |
| Meeting Title: | AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics |
| Journal Title: | Molecular Cancer Therapeutics |
| Volume: | 6 |
| Issue: | 12 |
| Meeting Dates: | 2007 Oct 22-26 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 1535-7163 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2007-12-01 |
| Start Page: | 3469S |
| End Page: | 3470S |
| Language: | English |
| ACCESSION: | WOS:000251969000412 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: B113 - Part 2 - "Source: Wos" |
MSK Authors
-
326Chapman